• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    GCC Microbiome Sequencing Services Market

    ID: MRFR/HC/52149-HCR
    200 Pages
    Garvit Vyas
    September 2025

    GCC Microbiome Sequencing Services Market Research Report: By Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Others) andBy Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    GCC Microbiome Sequencing Services Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    GCC Microbiome Sequencing Services Market Summary

    The GCC Microbiome Sequencing Services market is projected to experience substantial growth from 65.5 USD Million in 2024 to 335 USD Million by 2035.

    Key Market Trends & Highlights

    GCC Microbiome Sequencing Services Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate of 15.99 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 335 USD Million, indicating a robust expansion.
    • In 2024, the market is valued at 65.5 USD Million, highlighting its current significance in the region.
    • Growing adoption of microbiome sequencing technologies due to increasing awareness of personalized medicine is a major market driver.

    Market Size & Forecast

    2024 Market Size 65.5 (USD Million)
    2035 Market Size 335 (USD Million)
    CAGR (2025-2035) 15.99%

    Major Players

    CosmosID, Zymo Research, Asuragen, Pacific Biosciences, Qiagen, Stratos Genomics, Genomic Health, Thermo Fisher Scientific, Illumina, Ginkgo Bioworks, Oxford Nanopore Technologies, Genomatix, Microbiome Insights, Genomatica, Becton Dickinson

    GCC Microbiome Sequencing Services Market Trends

    The GCC Microbiome Sequencing Services Market is experiencing substantial growth as a result of the growing recognition of the microbiome's influence on human health and disease. The GCC region's governments are making significant investments in biotechnology and healthcare infrastructure, which has resulted in significant progress in the fields of genomics and microbiome research. Countries such as the United Arab Emirates and Saudi Arabia have implemented initiatives to encourage scientific innovation, which has resulted in an increase in the investigation of the microbiome. 

    This trend of government support encourages collaboration between academic institutions and research facilities, thereby increasing the demand for microbiome sequencing services. In recent years, there has been a growing interest in personalized medicine, with microbiome analysis being considered a critical component of the development of individualized healthcare solutions. The demand for sequencing services is increasing as healthcare providers seek to customize treatments based on microbiome profiles. Furthermore, the research community is increasingly interested in investigating the potential applications of microbiome sequencing in the fields of environmental science and agriculture. 

    This multidisciplinary approach creates additional opportunities for service providers by expanding the GCC market beyond clinical applications. Additionally, the microbiome-related research and services sector has significant potential for expansion due to the growing investments of the private sector and businesses that concentrate on health technology innovations.In the GCC market, microbiome sequencing is becoming more accessible and affordable due to advancements in data analysis tools and sequencing technologies. The microbiome sequencing sector is on the brink of significant growth as the region continues to embrace biotechnology and genomics, creating a plethora of opportunities for companies operating in this sector.

    GCC Microbiome Sequencing Services Market Drivers

    Market Segment Insights

    Microbiome Sequencing Services Market Technology Insights

    ,

    The Technology segment of the GCC Microbiome Sequencing Services Market is integral to the rapid advancement of genomic research and microbiome understanding in the region. This segment encompasses various methodologies, each offering unique capabilities and strengths that cater to a diverse range of applications. For instance, Sequencing by Litigation (SBL) is crucial for its ability to accurately capture the complexity of microbial communities, delivering insights that can greatly enhance disease prevention and treatment strategies.

    Similarly, Sequencing by Synthesis (SBS) is widely recognized for its high-throughput capabilities, enabling researchers to process large samples quickly and efficiently, which is particularly beneficial in both clinical and environmental studies. 

    Moreover, Shotgun Sequencing has become a dominant technique due to its comprehensive approach to capturing a vast array of genetic material, making it invaluable in both metagenomic studies and the exploration of microbial diversity. Targeted Gene Sequencing enhances precision by focusing on specific genes or regions of interest, thereby providing detailed information on gene functions and interactions, which is critical for personalized medicine initiatives. RNA Sequencing, on the other hand, is pivotal for understanding gene expression and regulation, further contributing to advancements in biotechnology and therapeutic development. 

    Collectively, these technologies not only support the GCC Microbiome Sequencing Services Market's growth but also highlight opportunities for innovation in microbiome research and applications across healthcare, agriculture, and environmental sustainability.As the GCC region continues to invest in biotechnology and genomic research, the demand for these sequencing technologies is expected to rise significantly. The growing awareness of the impact of the microbiome on health, disease, and ecosystems further propels this market segment, opening pathways for collaboration among research institutions, governmental bodies, and private enterprises. 

    Microbiome Sequencing Services Market Application Insights

    The Application segment of the GCC Microbiome Sequencing Services Market plays a critical role in advancing healthcare by harnessing the power of microbial genomics. A major focus is on gastrointestinal diseases, where microbiome analysis helps in understanding complex disorders, contributing to tailored therapeutics and better patient outcomes. Infectious diseases are another key area, as microbiome sequencing facilitates the identification of pathogens and resistance mechanisms, which enhances treatment strategies.

    Central nervous system (CNS) diseases are increasingly recognized for their link to gut microbiota, driving research into innovative interventions that may alleviate conditions such as Alzheimer’s and Parkinson’s.Oncology represents a significant frontier, with microbiome insights potentially influencing tumor growth and responses to immunotherapy. 

    Other applications also contribute to an expanding knowledge base, addressing diverse health issues through microbiome analysis. The increased recognition of the microbiome’s impact on health is driving market growth in the GCC region, as healthcare stakeholders invest in advanced sequencing technologies and platforms. This focus on integrated approaches underscores the importance of understanding microbial dynamics in improving public health outcomes across various medical disciplines.

    Get more detailed insights about GCC Microbiome Sequencing Services Market Research Report - Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The GCC Microbiome Sequencing Services Market is witnessing significant growth, driven by increasing awareness of the role microbiomes play in health, agriculture, and environmental sustainability. The competitive landscape in this market is shaped by the rapid advancement of sequencing technologies, enabling a diverse array of players to offer sophisticated microbiome analysis solutions. As interest in personalized medicine and the application of microbiome research spans various sectors, including healthcare, pharmaceuticals, and food production, companies are actively diversifying their services to meet the unique demands of this burgeoning market. 

    The competitive insights reveal that firms are not only enhancing their technological capabilities but also focusing on strategic collaborations, acquisitions, and geographical expansions within the Gulf Cooperation Council region to solidify their market presence.CosmosID is well-established in the GCC Microbiome Sequencing Services Market, primarily recognized for its advanced bioinformatics platform that provides precise microbial identification and characterization. 

    The company boasts a robust infrastructure for high-throughput sequencing, which allows for comprehensive analysis of complex microbiomes across various applications such as healthcare diagnostics, environmental monitoring, and agronomy. CosmosID's strengths lie in its proprietary analytics that enable clients to make data-driven decisions, thereby enhancing the accuracy and efficiency of microbiome research.

    Furthermore, CosmosID has fostered collaborative partnerships with research institutions and healthcare providers across the GCC region, facilitating the expansion of its service offerings and broadening its influence in the market.Zymo Research presents itself as a prominent player in the GCC Microbiome Sequencing Services Market, known for its innovative products and solutions that support microbiome research. 

    The company's key offerings include specialized kits for DNA and RNA extraction, library preparation, and comprehensive sequencing services tailored to microbiome studies. Zymo Research has established a strong market presence in the GCC region due to its commitment to quality and its ability to provide educational resources and technical support to its customers. The company has been actively involved in mergers and acquisitions, strengthening its expertise and expanding its portfolio of services specifically designed for microbiome applications.

    Zymo Research's strengths encompass its extensive product range, customer-centric approach, and an established network of collaborations that reinforce its position in the microbiome sequencing landscape within the GCC market.

    Key Companies in the GCC Microbiome Sequencing Services Market market include

    Industry Developments

    The GCC Microbiome Sequencing Services Market has experienced significant developments recently, including strong investments and technological advancements. In 2023, several companies like Qiagen and Illumina have expanded their operations in the GCC region, responding to the increasing demand for microbiome analysis in healthcare and agriculture. 

    Alongside this growth, the region has witnessed collaborations for Research and Development, fostering an innovative environment, particularly in Qatar and the UAE. In terms of mergers and acquisitions, there have been no major publicly known transactions among the specified companies in the last few months; however, the trend towards consolidation remains a focal point for future activity. For instance, Ginkgo Bioworks has been in discussions regarding potential partnerships with local firms to enhance its service offerings. 

    The GCC governments are also prioritizing biotechnology within their economic diversification strategies, aiming to turn the region into a hub for life sciences, thereby further boosting market potential. As a result, the valuation of the microbiome sequencing market is projected to grow significantly, driven by increasing awareness of personalized medicine and the ongoing digitization of healthcare services across the GCC countries.

    Market Segmentation

    Outlook

    • Gastrointestinal Diseases
    • Infectious Diseases
    • CNS Diseases
    • Oncology
    • Others

    Microbiome Sequencing Services Market Technology Outlook

    • Sequencing by Litigation (SBL)
    • Sequencing by Synthesis (SBS)
    • Short Gun Sequencing
    • Targeted Gene Sequencing
    • RNA Sequencing
    • Others

    Microbiome Sequencing Services Market Application Outlook

    • Gastrointestinal Diseases
    • Infectious Diseases
    • CNS Diseases
    • Oncology
    • Others

    Report Scope

    Report Scope:,,,,,,,,,,,,,
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 59.62(USD Million)
    MARKET SIZE 2024 65.52(USD Million)
    MARKET SIZE 2035 335.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 15.991% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED CosmosID, Zymo Research, Asuragen, Pacific Biosciences, Qiagen, Stratos Genomics, Genomic Health, Thermo Fisher Scientific, Illumina, Ginkgo Bioworks, Oxford Nanopore Technologies, Genomatix, Microbiome Insights, Genomatica, Becton Dickinson
    SEGMENTS COVERED Technology, Application
    KEY MARKET OPPORTUNITIES Rising demand for personalized medicine, Expanding research in gut health, Increased awareness of microbiome impact, Government funding for biotechnology, Growth in probiotic product development
    KEY MARKET DYNAMICS Growing healthcare investment, Increasing research funding, Rising prevalence of chronic diseases, Advancements in sequencing technologies, Expanding awareness of microbiome benefits
    COUNTRIES COVERED GCC

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Leave a Comment

    FAQs

    What is the market size of the GCC Microbiome Sequencing Services Market expected to be in 2024?

    In 2024, the GCC Microbiome Sequencing Services Market is expected to be valued at 65.52 USD Million.

    What is the projected market size for the GCC Microbiome Sequencing Services Market by 2035?

    By 2035, the market is projected to reach a valuation of 335.0 USD Million.

    What is the expected CAGR for the GCC Microbiome Sequencing Services Market between 2025 to 2035?

    The expected CAGR for the GCC Microbiome Sequencing Services Market during this period is 15.991%.

    Which technology segment is projected to have the highest market value by 2035?

    By 2035, RNA Sequencing is projected to have the highest market value at 85.0 USD Million.

    What are the key players in the GCC Microbiome Sequencing Services Market?

    Some key players include Illumina, Thermo Fisher Scientific, and Pacific Biosciences among others.

    How much is the Sequencing by Synthesis (SBS) segment expected to be valued in 2035?

    The Sequencing by Synthesis (SBS) segment is expected to be valued at 75.0 USD Million in 2035.

    What challenges might impact the growth of the GCC Microbiome Sequencing Services Market?

    Challenges may include regulatory hurdles and the high cost of sequencing technologies.

    What opportunities are present in the GCC Microbiome Sequencing Services Market?

    Increasing research in personalized medicine and chronic disease management presents significant opportunities.

    How does the GCC Microbiome Sequencing Services Market growth rate vary by technology segment?

    Each technology segment is expected to experience growth, with RNA Sequencing leading due to its increasing applications.

    What is the value of the Short Gun Sequencing segment in 2024?

    The Short Gun Sequencing segment is valued at 12.0 USD Million in 2024.

    1. Primary Interviews and Information Gathering Process 3.4.2. Breakdown of Primary
    2. Respondents 3.5. Forecasting Model 3.6. Market Size Estimation 3.6.1. Bottom-Up
    3. Approach 3.6.2. Top-Down Approach 3.7. Data Triangulation 3.8. Validation 4. MARKET
    4. DYNAMICS 4.1. Overview 4.2. Drivers 4.3. Restraints 4.4. Opportunities 5. MARKET FACTOR ANALYSIS 5.1. Value chain Analysis 5.2. Porter's Five Forces Analysis 5.2.1.
    5. Bargaining Power of Suppliers 5.2.2. Bargaining Power of Buyers 5.2.3. Threat of
    6. New Entrants 5.2.4. Threat of Substitutes 5.2.5. Intensity of Rivalry 5.3. COVID-19
    7. Impact Analysis 5.3.1. Market Impact Analysis 5.3.2. Regional Impact 5.3.3. Opportunity
    8. and Threat Analysis 6. GCC MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY
    9. (USD MILLION) 6.1. Sequencing by Litigation (SBL) 6.2. Sequencing by Synthesis (SBS)
      1. Short Gun Sequencing 6.4. Targeted Gene Sequencing 6.5. RNA Sequencing 6.6.
    10. Others 7. GCC MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION (USD MILLION)
      1. Gastrointestinal Diseases 7.2. Infectious Diseases 7.3. CNS Diseases 7.4. Oncology
      2. Others 8. COMPETITIVE LANDSCAPE 8.1. Overview 8.2. Competitive Analysis 8.3.
    11. Market share Analysis 8.4. Major Growth Strategy in the Microbiome Sequencing Services
    12. Market 8.5. Competitive Benchmarking 8.6. Leading Players in Terms of Number of
    13. Developments in the Microbiome Sequencing Services Market 8.7. Key developments
    14. and growth strategies 8.7.1. New Product Launch/Service Deployment 8.7.2. Merger
    15. & Acquisitions 8.7.3. Joint Ventures 8.8. Major Players Financial Matrix 8.8.1.
    16. Sales and Operating Income 8.8.2. Major Players R&D Expenditure. 2023 9. COMPANY
    17. PROFILES 9.1. CosmosID 9.1.1. Financial Overview 9.1.2. Products Offered 9.1.3.
    18. Key Developments 9.1.4. SWOT Analysis 9.1.5. Key Strategies 9.2. Zymo Research 9.2.1.
    19. Financial Overview 9.2.2. Products Offered 9.2.3. Key Developments 9.2.4. SWOT Analysis
      1. Key Strategies 9.3. Asuragen 9.3.1. Financial Overview 9.3.2. Products Offered
        1. Key Developments 9.3.4. SWOT Analysis 9.3.5. Key Strategies 9.4. Pacific
    20. Biosciences 9.4.1. Financial Overview 9.4.2. Products Offered 9.4.3. Key Developments
      1. SWOT Analysis 9.4.5. Key Strategies 9.5. Qiagen 9.5.1. Financial Overview
        1. Products Offered 9.5.3. Key Developments 9.5.4. SWOT Analysis 9.5.5. Key
    21. Strategies 9.6. Stratos Genomics 9.6.1. Financial Overview 9.6.2. Products Offered
      1. Key Developments 9.6.4. SWOT Analysis 9.6.5. Key Strategies 9.7. Genomic
    22. Health 9.7.1. Financial Overview 9.7.2. Products Offered 9.7.3. Key Developments
      1. SWOT Analysis 9.7.5. Key Strategies 9.8. Thermo Fisher Scientific 9.8.1.
    23. Financial Overview 9.8.2. Products Offered 9.8.3. Key Developments 9.8.4. SWOT Analysis
      1. Key Strategies 9.9. Illumina 9.9.1. Financial Overview 9.9.2. Products Offered
        1. Key Developments 9.9.4. SWOT Analysis 9.9.5. Key Strategies 9.10. Ginkgo
    24. Bioworks 9.10.1. Financial Overview 9.10.2. Products Offered 9.10.3. Key Developments
      1. SWOT Analysis 9.10.5. Key Strategies 9.11. Oxford Nanopore Technologies
        1. Financial Overview 9.11.2. Products Offered 9.11.3. Key Developments 9.11.4.
    25. SWOT Analysis 9.11.5. Key Strategies 9.12. Genomatix 9.12.1. Financial Overview
      1. Products Offered 9.12.3. Key Developments 9.12.4. SWOT Analysis 9.12.5.
    26. Key Strategies 9.13. Microbiome Insights 9.13.1. Financial Overview 9.13.2. Products
    27. Offered 9.13.3. Key Developments 9.13.4. SWOT Analysis 9.13.5. Key Strategies 9.14.
    28. Genomatica 9.14.1. Financial Overview 9.14.2. Products Offered 9.14.3. Key Developments
      1. SWOT Analysis 9.14.5. Key Strategies 9.15. Becton Dickinson 9.15.1. Financial
    29. Overview 9.15.2. Products Offered 9.15.3. Key Developments 9.15.4. SWOT Analysis
      1. Key Strategies 10. APPENDIX 10.1. References 10.2. Related Reports LIST
    30. OF TABLESTABLE 1. LIST OF ASSUMPTIONS TABLE 2. GCC MICROBIOME SEQUENCING SERVICES
    31. MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS) TABLE
    32. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION,
    33. 2035 (USD BILLIONS) TABLE 4. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL TABLE
    34. ACQUISITION/PARTNERSHIP LIST OF FIGURESFIGURE 1. MARKET SYNOPSIS FIGURE 2. GCC
    35. MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY TECHNOLOGY FIGURE 3. GCC MICROBIOME
    36. SEQUENCING SERVICES MARKET ANALYSIS BY APPLICATION FIGURE 4. KEY BUYING CRITERIA
    37. OF MICROBIOME SEQUENCING SERVICES MARKET FIGURE 5. RESEARCH PROCESS OF MRFR FIGURE
    38. DRO ANALYSIS OF MICROBIOME SEQUENCING SERVICES MARKET FIGURE 7. DRIVERS IMPACT
    39. ANALYSIS: MICROBIOME SEQUENCING SERVICES MARKET FIGURE 8. RESTRAINTS IMPACT ANALYSIS:
    40. MICROBIOME SEQUENCING SERVICES MARKET FIGURE 9. SUPPLY / VALUE CHAIN: MICROBIOME
    41. SEQUENCING SERVICES MARKET FIGURE 10. MICROBIOME SEQUENCING SERVICES MARKET, BY
    42. TECHNOLOGY, 2025 (% SHARE) FIGURE 11. MICROBIOME SEQUENCING SERVICES MARKET, BY
    43. TECHNOLOGY, 2019 TO 2035 (USD Billions) FIGURE 12. MICROBIOME SEQUENCING SERVICES
    44. MARKET, BY APPLICATION, 2025 (% SHARE) FIGURE 13. MICROBIOME SEQUENCING SERVICES
    45. MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions) FIGURE 14. BENCHMARKING OF MAJOR
    46. COMPETITORS

    GCC Microbiome Sequencing Services Market Segmentation

     

     

     

    • Microbiome Sequencing Services Market By Technology (USD Million, 2019-2035)

      • Sequencing by Litigation (SBL)
      • Sequencing by Synthesis (SBS)
      • Short Gun Sequencing
      • Targeted Gene Sequencing
      • RNA Sequencing
      • Others

     

    • Microbiome Sequencing Services Market By Application (USD Million, 2019-2035)

      • Gastrointestinal Diseases
      • Infectious Diseases
      • CNS Diseases
      • Oncology
      • Others

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials